Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Testosterone therapy significantly improved Hidradenitis Suppurativa symptoms.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Hyaluronic acid filler can safely and effectively improve facial contour in Parry-Romberg Syndrome.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Testosterone reduces heart damage and inflammation after injury.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

Red laser therapy helped regrow hair in an alopecia areata patient within 21 days.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

RNase L hinders hair follicle regeneration by altering immune signals.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

A new compound shows promise as a topical treatment for hair loss.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Hair intradermotherapy effectively treats hair loss and boosts self-esteem.

Microneedling radiofrequency significantly improves hair growth with minimal side effects.